<DOC>
	<DOCNO>NCT01896713</DOCNO>
	<brief_summary>MultiSpectral 3 Tesla MRI ( MS3TMRI ) increase yield Trans Rectal Ultrasound Biopsy ( TRUSBx ) improve identification patient active surveillance require treatment .</brief_summary>
	<brief_title>The Value MultiSpectral 3 Tesla MRI Active Surveillance Prostate Cancer</brief_title>
	<detailed_description>This prospective single arm study . 120 patient risk significant occult prostate cancer active surveillance program undergo MS3TMRI follow standard TRUSBx additional biopsy guide MS3TMRI result . The positive predictive value ( PPV ) MS3TMRI-TRUSBx cancer require consideration therapy compare PPV TRUSBx alone . MS3TMRI consist T2 , diffusion-weighted imaging ( DWI ) , dynamic contrast enhance MRI ( DCEMRI ) , proton MR spectroscopy ( MRS ) interpret radiologist CAD method validate whole mount prostate specimen .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Enrolled active surveillance Sunnybrook Health Sciences Centre , require biopsy part surveillance protocol . Clinically eligible radical prostatectomy willing undergo surgery Clinically eligible willing undergo ultrasound biopsy within 8 week MRI Claustrophobia Contraindication MRI Contraindication receive low molecular weight MRI contrast agent Prior hormone therapy except 5alpha reductase inhibitor Avodart . FloMax etc Clinically suspect know compromised renal function calculate estimate Glomerular Filtration Rate ( eGFR ) &lt; 30ml/min</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Prostate Cancer</keyword>
	<keyword>MRI</keyword>
	<keyword>TRUSBx</keyword>
</DOC>